个性化健康教育对抗COVID-19健康损害的老年匈牙利人群研究:自适应随机对照试验方案
PROACTIVE-19是一项在匈牙利60岁以上未确诊COVID-19人群中开展的实用型自适应随机对照试验,比较基于世界卫生组织建议的一般健康教育(A组)与个性化综合预防生活方式干预包(B组)对COVID-19复合终点的影响。主要终点为COVID-19阳性病例的ICU入住率、住院(超过48小时)率和死亡率,每臂估计样本量3788人,随访至少1年。
要点
- 在60岁以上未确诊COVID-19的匈牙利人群中比较一般与个性化健康教育。
- 个性化干预涵盖心理健康、吸烟、体力活动、饮食和饮酒五个领域。
- 复合主要终点为COVID-19阳性者的ICU入住、住院超过48小时和死亡。
核心结论
- 个性化综合预防生活方式干预可能增强心肺储备能力,从而减轻COVID-19造成的损害。
研究设计与样本
- 实用型随机对照临床试验,采用自适应样本量再估计设计。
- 研究对象为60岁以上、未确诊COVID-19的匈牙利人群,通过电话健康评估和生活方式咨询自愿参与。
- 受试者随机分为A组(一般健康教育)和B组(个性化健康教育),每臂估计样本量3788人,随访至少1年。
主要发现
- 早期报告显示COVID-19可能需要ICU入住的比例为5-26%,确诊病例总死亡率可升至11%,尤其影响老年人。
- 目前缺乏针对COVID-19预防和治疗的循证靶向药物治疗。
关键数值与推荐
- 两组均接受关于心理健康、吸烟习惯、体力活动、饮食习惯和饮酒五个领域的相同问题评估。
- 评估频率为第一个月每周一次,第二个月每两周一次,之后每月一次。
- 复合主要终点包括COVID-19阳性病例的ICU入住率、住院(超过48小时)率和死亡率。
临床怎么用
- 干预措施基于世界卫生组织建议,涵盖心理健康、吸烟、体力活动、饮食和饮酒五个领域。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early reports indicate that COVID-19 may require intensive care unit (ICU) admission in 5-26% and overall mortality can rise to 11% of the recognised cases, particularly affecting the elderly. There is a lack of evidence-based targeted pharmacological therapy for its prevention and treatment. We aim to compare the effects of a World Health Organization recommendation-based education and a personalised complex preventive lifestyle intervention package (based on the same WHO recommendation) on the outcomes of the COVID-19. METHODS: PROACTIVE-19 is a pragmatic, randomised controlled clinical trial with adaptive "sample size re-estimation" design. Hungarian population over the age of 60 years without confirmed COVID-19 will be approached to participate in a telephone health assessment and lifestyle counselling voluntarily. Volunteers will be randomised into two groups: (A) general health education and (B) personalised health education. Participants will go through questioning and recommendation in 5 fields: (1) mental health, (2) smoking habits, (3) physical activity, (4) dietary habits, and (5) alcohol consumption. Both groups A and B will receive the same line of questioning to assess habits concerning these topics. Assessment will be done weekly during the first month, every second week in the second month, then monthly. The composite primary endpoint will include the rate of ICU admission, hospital admission (longer than 48 h), and mortality in COVID-19-positive cases. The estimated sample size is 3788 subjects per study arm. The planned duration of the follow-up is a minimum of 1 year. DISCUSSION: These interventions may boost the body's cardiovascular and pulmonary reserve capacities, leading to improved resistance against the damage caused by COVID-19. Consequently, lifestyle changes can reduce the incidence of life-threatening conditions and attenuate the detrimental effects of the pandemic seriously affecting the older population. TRIAL REGISTRATION: The study has been approved by the Scientific and Research Ethics Committee of the Hungarian Medical Research Council (IV/2428- 2 /2020/EKU) and has been registered at clinicaltrials.gov ( NCT04321928 ) on 25 March 2020.
引用
- Erőss B, Molnár Z, Szakács Z, et al. Personalised health education against health damage of COVID-19 epidemic in the elderly Hungarian population (PROACTIVE-19): protocol of an adaptive randomised controlled clinical trial. Trials. 2020. PMID: 32993779. doi:10.1186/s13063-020-04733-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。